[
  {
    "ts": null,
    "headline": "Top 2 Healthcare Stocks Every New Investor Should Know",
    "summary": "These healthcare stocks have long-term and profitable growth runways.",
    "url": "https://finnhub.io/api/news?id=487ed04ec3ab7831ef5b63a1f1ed062943552159a3369adc0e49fb7b05a35fa6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763730900,
      "headline": "Top 2 Healthcare Stocks Every New Investor Should Know",
      "id": 137572203,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "These healthcare stocks have long-term and profitable growth runways.",
      "url": "https://finnhub.io/api/news?id=487ed04ec3ab7831ef5b63a1f1ed062943552159a3369adc0e49fb7b05a35fa6"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on Abbott, Ryman Healthcare, Novartis and more in the latest Market Talks covering the health care sector.",
    "url": "https://finnhub.io/api/news?id=c9b959f018e886f8aa4dc1e8481b87a868fa53c782a9498fdd19dac08e27016a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763728320,
      "headline": "Health Care Roundup: Market Talk",
      "id": 137572204,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Find insight on Abbott, Ryman Healthcare, Novartis and more in the latest Market Talks covering the health care sector.",
      "url": "https://finnhub.io/api/news?id=c9b959f018e886f8aa4dc1e8481b87a868fa53c782a9498fdd19dac08e27016a"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories: Not Passing The Test, After Buying Test Maker Exact Sciences",
    "summary": "Abbott's $23B Exact Sciences deal adds short-term risk and earnings dilution. Read what this means for investors and when value could improve.",
    "url": "https://finnhub.io/api/news?id=ea97bdf421c3fcd02eb98c47130e4c1b41f83bf647aa005cea6b39cc7650e692",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763726061,
      "headline": "Abbott Laboratories: Not Passing The Test, After Buying Test Maker Exact Sciences",
      "id": 137569999,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2155841301/image_2155841301.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Abbott's $23B Exact Sciences deal adds short-term risk and earnings dilution. Read what this means for investors and when value could improve.",
      "url": "https://finnhub.io/api/news?id=ea97bdf421c3fcd02eb98c47130e4c1b41f83bf647aa005cea6b39cc7650e692"
    }
  },
  {
    "ts": null,
    "headline": "Weekly Recap: 14 Health Press Releases You Need to See",
    "summary": "With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.",
    "url": "https://finnhub.io/api/news?id=4eedf115c4c27b3251e1e0b2d79d04b0fb166f541ceb3f5fd03322804ccd55f8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763724120,
      "headline": "Weekly Recap: 14 Health Press Releases You Need to See",
      "id": 137572205,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.",
      "url": "https://finnhub.io/api/news?id=4eedf115c4c27b3251e1e0b2d79d04b0fb166f541ceb3f5fd03322804ccd55f8"
    }
  },
  {
    "ts": null,
    "headline": "Abbott’s $21B Exact Sciences buy reveals future strategy",
    "summary": "The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing.",
    "url": "https://finnhub.io/api/news?id=2804e0b97b3a45c90951acc9e8b15ad80a2626f69b49fa88a6f5c17cfd4b28b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763722536,
      "headline": "Abbott’s $21B Exact Sciences buy reveals future strategy",
      "id": 137572206,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing.",
      "url": "https://finnhub.io/api/news?id=2804e0b97b3a45c90951acc9e8b15ad80a2626f69b49fa88a6f5c17cfd4b28b5"
    }
  },
  {
    "ts": null,
    "headline": "2 Fantastic Dividend Stocks to Buy and Hold Forever",
    "summary": "These companies have been raising their payouts for a combined 101 consecutive years.",
    "url": "https://finnhub.io/api/news?id=ac8ba28304904ad230c5154d428259c2befc63e523ebcd18f0853100c6fd684b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763722020,
      "headline": "2 Fantastic Dividend Stocks to Buy and Hold Forever",
      "id": 137572207,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "These companies have been raising their payouts for a combined 101 consecutive years.",
      "url": "https://finnhub.io/api/news?id=ac8ba28304904ad230c5154d428259c2befc63e523ebcd18f0853100c6fd684b"
    }
  },
  {
    "ts": null,
    "headline": "Abbott to acquire all outstanding shares in Exact Sciences",
    "summary": "The transaction includes the absorption of Exact Sciences’ estimated net debt of $1.8bn.",
    "url": "https://finnhub.io/api/news?id=172f64cc8543057d5d999ba05506e9a3927078962fdc6c886ba7b790689b9d68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763718636,
      "headline": "Abbott to acquire all outstanding shares in Exact Sciences",
      "id": 137572208,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The transaction includes the absorption of Exact Sciences’ estimated net debt of $1.8bn.",
      "url": "https://finnhub.io/api/news?id=172f64cc8543057d5d999ba05506e9a3927078962fdc6c886ba7b790689b9d68"
    }
  }
]